Literature DB >> 24900494

Synthesis and biochemical evaluation of thiochromanone thiosemicarbazone analogues as inhibitors of cathepsin L.

Jiangli Song1, Lindsay M Jones1, G D Kishore Kumar1, Elizabeth S Conner1, Liela Bayeh1, Gustavo E Chavarria1, Amanda K Charlton-Sevcik1, Shen-En Chen1, David J Chaplin2, Mary Lynn Trawick1, Kevin G Pinney1.   

Abstract

A series of 36 thiosemicarbazone analogues containing the thiochromanone molecular scaffold functionalized primarily at the C-6 position were prepared by chemical synthesis and evaluated as inhibitors of cathepsins L and B. The most promising inhibitors from this group are selective for cathepsin L and demonstrate IC50 values in the low nanomolar range. In nearly all cases, the thiochromanone sulfide analogues show superior inhibition of cathepsin L as compared to their corresponding thiochromanone sulfone derivatives. Without exception, the compounds evaluated were inactive (IC50 > 10000 nM) against cathepsin B. The most potent inhibitor (IC50 = 46 nM) of cathepsin L proved to be the 6,7-difluoro analogue 4. This small library of compounds significantly expands the structure-activity relationship known for small molecule, nonpeptidic inhibitors of cathepsin L.

Entities:  

Keywords:  cathepsin B; cathepsin L; inhibitor; thiochromanone; thiosemicarbazone

Year:  2012        PMID: 24900494      PMCID: PMC4025852          DOI: 10.1021/ml200299g

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  20 in total

Review 1.  Development of cathepsin inhibitors and structure-based design of cathepsin B-specific inhibitor.

Authors:  Koji Tomoo
Journal:  Curr Top Med Chem       Date:  2010       Impact factor: 3.295

Review 2.  Targeting proteases: successes, failures and future prospects.

Authors:  Boris Turk
Journal:  Nat Rev Drug Discov       Date:  2006-09       Impact factor: 84.694

Review 3.  Cysteine cathepsins and the cutting edge of cancer invasion.

Authors:  Vasilena Gocheva; Johanna A Joyce
Journal:  Cell Cycle       Date:  2007-01-06       Impact factor: 4.534

4.  Functionalized benzophenone, thiophene, pyridine, and fluorene thiosemicarbazone derivatives as inhibitors of cathepsin L.

Authors:  G D Kishore Kumar; Gustavo E Chavarria; Amanda K Charlton-Sevcik; Grace Kim Yoo; Jiangli Song; Tracy E Strecker; Bronwyn G Siim; David J Chaplin; Mary Lynn Trawick; Kevin G Pinney
Journal:  Bioorg Med Chem Lett       Date:  2010-09-15       Impact factor: 2.823

Review 5.  Cathepsin L, target in cancer treatment?

Authors:  Jacqueline M Lankelma; Daniëlle M Voorend; Temo Barwari; Joris Koetsveld; Anne H Van der Spek; Alexander P N A De Porto; Geeske Van Rooijen; Cornelis J F Van Noorden
Journal:  Life Sci       Date:  2009-11-30       Impact factor: 5.037

6.  Structure-guided development of selective TbcatB inhibitors.

Authors:  Jeremy P Mallari; Anang A Shelat; Aaron Kosinski; Conor R Caffrey; Michele Connelly; Fangyi Zhu; James H McKerrow; R Kiplin Guy
Journal:  J Med Chem       Date:  2009-10-22       Impact factor: 7.446

7.  Increased expression and activity of nuclear cathepsin L in cancer cells suggests a novel mechanism of cell transformation.

Authors:  Brigitte Goulet; Laurent Sansregret; Lam Leduy; Matthew Bogyo; Ekkehard Weber; Shyam S Chauhan; Alain Nepveu
Journal:  Mol Cancer Res       Date:  2007-09       Impact factor: 5.852

8.  Discovery of trypanocidal thiosemicarbazone inhibitors of rhodesain and TbcatB.

Authors:  Jeremy P Mallari; Anang Shelat; Aaron Kosinski; Conor R Caffrey; Michele Connelly; Fangyi Zhu; James H McKerrow; R Kiplin Guy
Journal:  Bioorg Med Chem Lett       Date:  2008-04-08       Impact factor: 2.823

9.  Synthesis and structure-activity relationship study of potent trypanocidal thio semicarbazone inhibitors of the trypanosomal cysteine protease cruzain.

Authors:  Xiaohui Du; Chun Guo; Elizabeth Hansell; Patricia S Doyle; Conor R Caffrey; Tod P Holler; James H McKerrow; Fred E Cohen
Journal:  J Med Chem       Date:  2002-06-20       Impact factor: 7.446

10.  Design, synthesis, and biological evaluation of potent thiosemicarbazone based cathepsin L inhibitors.

Authors:  G D Kishore Kumar; Gustavo E Chavarria; Amanda K Charlton-Sevcik; Wara M Arispe; Matthew T Macdonough; Tracy E Strecker; Shen-En Chen; Bronwyn G Siim; David J Chaplin; Mary Lynn Trawick; Kevin G Pinney
Journal:  Bioorg Med Chem Lett       Date:  2010-01-06       Impact factor: 2.823

View more
  6 in total

1.  3-Cyano-3-aza-β-amino Acid Derivatives as Inhibitors of Human Cysteine Cathepsins.

Authors:  Janina Schmitz; Anna-Madeleine Beckmann; Adela Dudic; Tianwei Li; Robert Sellier; Ulrike Bartz; Michael Gütschow
Journal:  ACS Med Chem Lett       Date:  2014-08-11       Impact factor: 4.345

2.  Synthesis and biochemical evaluation of benzoylbenzophenone thiosemicarbazone analogues as potent and selective inhibitors of cathepsin L.

Authors:  Erica N Parker; Jiangli Song; G D Kishore Kumar; Samuel O Odutola; Gustavo E Chavarria; Amanda K Charlton-Sevcik; Tracy E Strecker; Ashleigh L Barnes; Dhivya R Sudhan; Thomas R Wittenborn; Dietmar W Siemann; Michael R Horsman; David J Chaplin; Mary Lynn Trawick; Kevin G Pinney
Journal:  Bioorg Med Chem       Date:  2015-09-25       Impact factor: 3.641

3.  CO2 Electrolysis via Surface-Engineering Electrografted Pyridines on Silver Catalysts.

Authors:  Maryam Abdinejad; Erdem Irtem; Amirhossein Farzi; Mark Sassenburg; Siddhartha Subramanian; Hugo-Pieter Iglesias van Montfort; Davide Ripepi; Mengran Li; Joost Middelkoop; Ali Seifitokaldani; Thomas Burdyny
Journal:  ACS Catal       Date:  2022-06-17       Impact factor: 13.700

4.  Hydrazone Derivatives Enhance Antileishmanial Activity of Thiochroman-4-ones.

Authors:  Esteban Vargas; Fernando Echeverri; Yulieth A Upegui; Sara M Robledo; Wiston Quiñones
Journal:  Molecules       Date:  2017-12-29       Impact factor: 4.411

5.  Cathepsin L secretion by host and neoplastic cells potentiates invasion.

Authors:  Samantha S Dykes; Henrietta O Fasanya; Dietmar W Siemann
Journal:  Oncotarget       Date:  2019-09-17

6.  New chroman-4-one/thiochroman-4-one derivatives as potential anticancer agents.

Authors:  Seref Demirayak; Leyla Yurttas; Nalan Gundogdu-Karaburun; Ahmet Cagri Karaburun; Ismail Kayagil
Journal:  Saudi Pharm J       Date:  2017-04-26       Impact factor: 4.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.